Prostate enlargement and cancer
Benign prostate enlargement is one of the most frequent health disorders in men. As this gland becomes enlarged, it places pressure on the bladder and urethra, which may cause difficulty starting to pee and a frequent need to pee.
At the age of 60, half of all men suffer from it and the percentage rises to 90% beyond the age of 80. Specialists recommend an annual prostate check from the age of 40 onwards. It is important to note that prostate enlargement is not usually a serious condition, nor does it have any relation to prostate cancer.
Below are a few key procedures and techniques related to prostate enlargement and cancer, conducted at Hospital Ochoa’s Urology Department:
Holmium laser prostate surgery (HoLEP). The Holmium laser treatment for an enlarged prostate is minimally invasive and offers fast recovery and symptom relief. The laser removes tissue that is blocking urine flow through the prostate, and a separate instrument is then used to cut the prostate tissue into easily removable fragments. It coagulates while cutting and does not damage surrounding tissue, thus reducing bleeding. The operation lasts one hour and is performed endoscopically. It requires a hospital stay of 24-48 hours and surgical reintervention is never necessary due to successful prostate tissue regrowth. This laser can also be applied to kidney stones, ureter tumors and urethral stenosis.
Fusion guided prostate biopsy. This procedure greatly surpasses the previous transrectal biopsy as it allows for an earlier and more accurate diagnosis. The greater accuracy is achieved by means of an MRI ultrasound, and performing the puncture through the perineum leads to a lower rate of bleeding and a better recovery time. The subsequent localised treatment of tumours may be conducted with irreversible electroporation (NanoKnife), an innovative technique which is only performed in a few hospitals in Spain.
Irreversible electroporation (NanoKnife). This technique facilitates the safe and accurate surgical ablation of body areas that lie next to vessels and ducts, such as for example prostate cancer. Needle probes controlled by CT or ultrasound emit microsecond electrical pulses which open pores in cell membranes. With sufficient energy, the cells die and are cleared away by the lymphatic system. NanoKnife is non-thermal so it poses no heat dissipation problems and does not affect blood vessels or other critical structures. Hospitalisation lasts one day only, and the patient can return to work within 48 hours without any symptoms.